Home > Qtrly Results > ANTHEM BIOSCIENCES

ANTHEM BIOSCIENCES
Quarterly Results Analysis [Mar2026]

ANTHEM BIOSCIENCES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for ANTHEM BIOSCIENCES
Please provide your vote to see the results

ANTHEM BIOSCIENCES Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
Audited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
Audited
Revenues ₹611 Cr ₹423 Cr ₹550 Cr ₹540 Cr ₹483 Cr ₹498 Cr ₹525 Cr ₹339 Cr
Expenses ₹344 Cr ₹266 Cr ₹332 Cr ₹349 Cr ₹288 Cr ₹338 Cr ₹330 Cr ₹218 Cr
Operating Income ₹267 Cr ₹157 Cr ₹218 Cr ₹191 Cr ₹195 Cr ₹160 Cr ₹195 Cr ₹121 Cr
Other Income ₹51 Cr ₹34 Cr ₹48 Cr ₹23 Cr ₹14 Cr ₹24 Cr ₹28 Cr ₹19 Cr
Interest ₹2 Cr ₹0 Cr ₹3 Cr ₹2 Cr ₹1 Cr ₹3 Cr ₹4 Cr ₹4 Cr
Depreciation ₹40 Cr ₹35 Cr ₹33 Cr ₹26 Cr ₹30 Cr ₹20 Cr ₹20 Cr ₹19 Cr
Profit Before Tax ₹278 Cr ₹130 Cr ₹230 Cr ₹186 Cr ₹178 Cr ₹161 Cr ₹200 Cr ₹118 Cr
Profit After Tax ₹190 Cr ₹93 Cr ₹173 Cr ₹136 Cr ₹83 Cr ₹124 Cr ₹162 Cr ₹82 Cr
EPS ₹3.38 ₹1.65 ₹3.09 ₹2.42 ₹1.48 ₹2.22 ₹2.90 ₹1.47
Industry Peers & Returns1W1M1Y
ANTHEM BIOSCIENCES 1.3% 2.3% NA
SUN PHARMACEUTICAL INDUSTRIES 0.5% 4.6% 11.7%
DIVIS LABORATORIES -0.6% 2.2% -0.6%
TORRENT PHARMACEUTICALS 3.2% 8.1% 43.9%
CIPLA 1.1% 5.6% -3.5%
DR REDDYS LABORATORIES -0.3% 5.6% -0.1%
MANKIND PHARMA 1.1% 8.2% 7.9%
LUPIN 2.4% 6.6% 23.8%
ZYDUS LIFESCIENCES -0.2% 2.1% 13.7%

ANTHEM BIOSCIENCES Quarterly Revenues

Revenues
Q-o-Q

44.38 %

Y-o-Y

26.44 %

Quarters Revenues % Change
Mar2026 ₹611 Cr
44.38
Dec2025 ₹423 Cr
-23.07
Sep2025 ₹550 Cr
1.82
Jun2025 ₹540 Cr
11.80
Mar2025 ₹483 Cr
-2.93
Dec2024 ₹498 Cr
-5.17
Sep2024 ₹525 Cr
55.04
Jun2024 ₹339 Cr -

ANTHEM BIOSCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

69.98 %

Y-o-Y

36.90 %

Quarters Operating Profit % Change
Mar2026 ₹267 Cr
69.98
Dec2025 ₹157 Cr
-27.86
Sep2025 ₹218 Cr
13.79
Jun2025 ₹191 Cr
-1.90
Mar2025 ₹195 Cr
22.37
Dec2024 ₹160 Cr
-18.30
Sep2024 ₹195 Cr
61.48
Jun2024 ₹121 Cr -
Operating Margins
Q-o-Q

17.74 %

Y-o-Y

8.27 %

Quarters Operating Margin% % Change
Mar2026 43.74%
17.74
Dec2025 37.15%
-6.23
Sep2025 39.62%
11.76
Jun2025 35.45%
-12.25
Mar2025 40.4%
26.09
Dec2024 32.04%
-13.85
Sep2024 37.19%
4.14
Jun2024 35.71% -

ANTHEM BIOSCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

104.44 %

Y-o-Y

129.67 %

Quarters Profit After Tax % Change
Mar2026 ₹190 Cr
104.44
Dec2025 ₹93 Cr
-46.48
Sep2025 ₹173 Cr
27.72
Jun2025 ₹136 Cr
64.35
Mar2025 ₹83 Cr
-33.55
Dec2024 ₹124 Cr
-23.22
Sep2024 ₹162 Cr
96.56
Jun2024 ₹82 Cr -
PAT Margins
Q-o-Q

41.63 %

Y-o-Y

81.64 %

Quarters PAT Margin(%) % Change
Mar2026 31.06 %
41.63
Dec2025 21.93 %
-30.45
Sep2025 31.53 %
25.42
Jun2025 25.14 %
47.02
Mar2025 17.1 %
-31.55
Dec2024 24.98 %
-19.03
Sep2024 30.85 %
26.80
Jun2024 24.33 % -

ANTHEM BIOSCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

104.85 %

Y-o-Y

128.38 %

Quarters EPS % Change
Mar2026 ₹3.38
104.85
Dec2025 ₹1.65
-46.60
Sep2025 ₹3.09
27.69
Jun2025 ₹2.42
63.51
Mar2025 ₹1.48
-33.33
Dec2024 ₹2.22
-23.45
Sep2024 ₹2.9
97.28
Jun2024 ₹1.47 -

You may also like the below Video Courses